Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
NKC|ntk20221151674
(VIAF cluster)
|
003
|
|
|
NKC |
005
|
|
|
20220822144443.0 |
008
|
|
|
220525|n|aznnnaabn n a|a |
035
|
|
|
‡a
(NKC)ntk20221151674
|
024
|
7 |
|
‡a
0000000495570582
‡2
isni
|
024
|
7 |
|
‡a
0000-0002-1621-3372
‡2
orcid
|
040
|
|
|
‡a
ABA013
‡b
cze
‡e
rda
|
046
|
|
|
‡f
1971
|
100
|
1 |
|
‡a
Thompson, Paul R.
‡q
(Paul Ryan),
‡d
1971-
‡7
ntk20221151674
|
368
|
|
|
‡d
PDF (Pharmacology)
‡s
2003
|
368
|
|
|
‡d
PhD (Biochemistry)
‡s
2000
|
368
|
|
|
‡d
BSc (Biochemistry)
‡s
1994
|
370
|
|
|
‡c
Spojené státy americké
|
372
|
|
|
‡a
biochemie
‡a
farmakologie
‡a
chemoterapeutika
‡a
maligní nádorová onemocnění
‡a
revmatoidní artritida
|
373
|
|
|
‡a
University of Massachusetts Medical School
‡s
2014
|
374
|
|
|
‡a
biochemici
‡a
farmakologové
‡a
vysokoškolští učitelé
‡a
vědci
|
375
|
|
|
‡a
muž
|
377
|
|
|
‡a
eng
|
400
|
1 |
|
‡a
Thompson, Paul Ryan,
‡d
1971-
‡0
o
|
670
|
|
|
‡a
Nicholas, Anthony P. - Bhattacharya, Sanjoy K. - Thompson, Paul R. (eds.): Protein deimination in human health and disease, c2017
‡b
afiliace
|
670
|
|
|
‡a
LC (Names), cit. 25. 5. 2022
‡b
autoritní forma, datum narození
|
670
|
|
|
‡a
www(University of Massachusetts Medical School), cit. 25. 5. 2022
‡b
profesní údaje
‡u
https://www.umassmed.edu/thompson/lab-members/principal-investigator/
|
678
|
0 |
|
‡a
Vysokoškolský pedagog a odborník v oblasti biochemie a farmakologie, specializuje se na design chemoterapeutik proti rakovině a revmatoidní artritidě. Publikace v oboru.
|
909
|
|
|
‡a
(isni) 0000000495570582
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000216213372
‡9
1
|
945
|
|
|
‡a
farmakologove
‡A
farmakologové
‡9
1
|
945
|
|
|
‡a
vysokoskolsti ucitele
‡A
vysokoškolští učitelé
‡9
1
|
945
|
|
|
‡a
vedci
‡A
vědci
‡9
1
|
945
|
|
|
‡a
biochemici
‡A
biochemici
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
947
|
|
|
‡a
Spojené státy americké
‡9
1
|
948
|
|
|
‡a
eng
‡9
1
|
970
|
|
|
‡a
biochemie
‡A
biochemie
‡9
1
|
970
|
|
|
‡a
farmakologie
‡A
farmakologie
‡9
1
|
970
|
|
|
‡a
chemoterapeutika
‡A
chemoterapeutika
‡9
1
|
970
|
|
|
‡a
maligni nadorova onemocneni
‡A
maligní nádorová onemocnění
‡9
1
|
970
|
|
|
‡a
revmatoidni artritida
‡A
revmatoidní artritida
‡9
1
|
996
|
|
|
‡2
WKP|Q7153990
|
996
|
|
|
‡2
WKP|Q7153991
|
996
|
|
|
‡2
ISNI|0000000433862926
|
996
|
|
|
‡2
LC|no2018017042
|
996
|
|
|
‡2
DNB|1046183915
|
996
|
|
|
‡2
DNB|1181990106
|
996
|
|
|
‡2
DE633|pe30092823
|
996
|
|
|
‡2
LC|no2003008699
|
996
|
|
|
‡2
ISNI|0000000041586627
|
996
|
|
|
‡2
WKP|Q57523329
|
996
|
|
|
‡2
CAOONL|ncf11399025
|
996
|
|
|
‡2
WKP|Q67209993
|
996
|
|
|
‡2
ISNI|0000000071908703
|
996
|
|
|
‡2
SUDOC|25406485X
|
996
|
|
|
‡2
N6I|vtls002240116
|
996
|
|
|
‡2
LC|no2008121859
|
996
|
|
|
‡2
ISNI|0000000118911089
|
996
|
|
|
‡2
WKP|Q7153989
|
996
|
|
|
‡2
BIBSYS|5071913
|
996
|
|
|
‡2
LC|no2011118417
|
996
|
|
|
‡2
WKP|Q88477516
|
996
|
|
|
‡2
LC|n 82217767
|
996
|
|
|
‡2
LC|no2023113727
|
996
|
|
|
‡2
NTA|189502118
|
996
|
|
|
‡2
LC|nb 90055629
|
996
|
|
|
‡2
WKP|Q57849944
|
996
|
|
|
‡2
ISNI|0000000045848145
|
996
|
|
|
‡2
LC|n 2019061694
|
996
|
|
|
‡2
WKP|Q64020778
|
996
|
|
|
‡2
NII|DA15710484
|
996
|
|
|
‡2
ISNI|0000000391320124
|
996
|
|
|
‡2
ISNI|0000000107521923
|
996
|
|
|
‡2
BLBNB|001458150
|
996
|
|
|
‡2
NUKAT|n 2009115789
|
996
|
|
|
‡2
ISNI|0000000495570582
|
996
|
|
|
‡2
ISNI|0000000030319478
|
996
|
|
|
‡2
SUDOC|263574598
|
996
|
|
|
‡2
BNF|16071699
|
996
|
|
|
‡2
WKP|Q101212717
|
996
|
|
|
‡2
WKP|Q75770791
|
996
|
|
|
‡2
DNB|134539427
|
996
|
|
|
‡2
NII|DA01693456
|
996
|
|
|
‡2
DNB|1203735464
|
996
|
|
|
‡2
LC|no2010135104
|
996
|
|
|
‡2
WKP|Q113125766
|
996
|
|
|
‡2
LC|no2022085979
|
996
|
|
|
‡2
NII|DA0512981X
|
996
|
|
|
‡2
DNB|1227010087
|
996
|
|
|
‡2
SZ|1176144820
|
996
|
|
|
‡2
WKP|Q18387155
|
996
|
|
|
‡2
DNB|1198339365
|
996
|
|
|
‡2
DNB|1158214235
|
996
|
|
|
‡2
DNB|1176144820
|
996
|
|
|
‡2
NTA|262267977
|
996
|
|
|
‡2
WKP|Q104752362
|
996
|
|
|
‡2
WKP|Q64856717
|
996
|
|
|
‡2
WKP|Q35092131
|
996
|
|
|
‡2
SUDOC|256634823
|
996
|
|
|
‡2
WKP|Q58638845
|
996
|
|
|
‡2
LC|nb2004312261
|
996
|
|
|
‡2
WKP|Q86596647
|
996
|
|
|
‡2
RERO|A014071244
|
996
|
|
|
‡2
PTBNP|159602
|
996
|
|
|
‡2
ISNI|0000000514838151
|
996
|
|
|
‡2
LC|nb2005001734
|
996
|
|
|
‡2
LC|n 2016024509
|
996
|
|
|
‡2
RERO|A022949030
|
996
|
|
|
‡2
WKP|Q60198615
|
996
|
|
|
‡2
NSK|000244767
|
996
|
|
|
‡2
DNB|1059822229
|
996
|
|
|
‡2
LC|no 99041518
|
996
|
|
|
‡2
NUKAT|n 2018040261
|
996
|
|
|
‡2
WKP|Q97685845
|
996
|
|
|
‡2
WKP|Q57941372
|
996
|
|
|
‡2
WKP|Q64624951
|
996
|
|
|
‡2
PLWABN|9810672321705606
|
996
|
|
|
‡2
WKP|Q102210100
|
996
|
|
|
‡2
DNB|1011177595
|
996
|
|
|
‡2
NSK|000375665
|
996
|
|
|
‡2
DNB|127749381
|
996
|
|
|
‡2
DNB|1165187884
|
996
|
|
|
‡2
NSK|000046955
|
996
|
|
|
‡2
NLA|000035547970
|
996
|
|
|
‡2
SUDOC|25820334X
|
996
|
|
|
‡2
LC|n 93074326
|
996
|
|
|
‡2
RERO|A027542304
|
996
|
|
|
‡2
ISNI|0000000032375297
|
996
|
|
|
‡2
ISNI|000000038196329X
|
996
|
|
|
‡2
DNB|1157139280
|
996
|
|
|
‡2
DNB|123615534
|
996
|
|
|
‡2
WKP|Q58497119
|
996
|
|
|
‡2
DNB|118622234
|
996
|
|
|
‡2
NTA|13870046X
|
996
|
|
|
‡2
SUDOC|061672084
|
996
|
|
|
‡2
ISNI|0000000044933460
|
996
|
|
|
‡2
CAOONL|ncf10072666
|
996
|
|
|
‡2
ISNI|0000000024574624
|
996
|
|
|
‡2
LC|n 2018183644
|
997
|
|
|
‡a
1971 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Thompson, Paul R
‡2
ISNI|0000000495570582
‡3
suggested
|
998
|
|
|
‡a
Paul R Thompson
‡c
researcher
‡2
WKP|Q63368426
‡3
suggested
‡3
standard number
|
998
|
|
|
‡a
Thompson, Paul R.
‡q
(Paul Ryan),
‡2
LC|n 2018183644
‡3
single date
|